Spartan Fund Management Inc. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 54 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Spartan Fund Management Inc. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$4,200
-79.9%
75,000
-85.2%
0.00%
-40.0%
Q2 2023$20,902
+248.4%
507,159
+576.2%
0.01%
+66.7%
Q1 2023$6,000
+199900.0%
75,0000.0%0.00%
+200.0%
Q4 2022$3
-100.0%
75,0000.0%0.00%
-66.7%
Q3 2022$11,00075,0000.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 200,049$2,007,0000.05%
Q Global Advisors, LLC 195,489$18,0000.01%
RAMIUS ADVISORS LLC 196,073$16,0000.01%
EHP Funds Inc. 137,276$20,0000.00%
Telemetry Investments, L.L.C. 33,303$3,0000.00%
MARSHALL WACE, LLP 190,150$1,930,0000.00%
PERISCOPE CAPITAL INC. 735,572$97,0000.00%
Spartan Fund Management Inc. 75,000$11,0000.00%
Union Square Park Capital Management, LLC 25,000$2,0000.00%
KIM, LLC 250,000$36,0000.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders